Active gastritis typically requires treatment and symptom control before beginning GLP-1 therapy
Im pulling this out of my having read Daniel Steinbergs papers
BMI of 30 or higher (obesity) BMI of 27 or higher with at least one weight-related condition (hypertension, high cholesterol, sleep apnea, Type 2 diabetes, or cardiovascular disease) Prior difficulty maintaining weight loss through diet and exercise alone No contraindicated medical history (reviewed at consultation) Commitment to regular monitoring and follow-up visits Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Prior serious hypersensitivity reaction to semaglutide or excipients Current pregnancy or active breastfeeding Certain pancreatic conditions (evaluated at consultation) Not sure if you qualify
For many people, they finally provide something that feels differentmore control, more consistency, and a sense of possibility that may not have been there before
8,000 to as high as Rs
In practical terms, patients on tirzepatide often experience stronger appetite reduction, fewer cravings, and more significant weight loss over a comparable treatment period
